{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T04:24:30Z","timestamp":1786940670980,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-026-06237-7","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:57:39Z","timestamp":1783997859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bladder carcinoma associated with anti-NXP2-positive inflammatory myopathy: a case-based review"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0907-2505","authenticated-orcid":false,"given":"Nayan","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4113-9186","authenticated-orcid":false,"given":"Mritunjai","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5136-7254","authenticated-orcid":false,"given":"Ravi Hari","family":"Phulware","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"issue":"5","key":"6237_CR1","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/annrheumdis-2011-200697","volume":"71","author":"Y Ichimura","year":"2012","unstructured":"Ichimura Y, Matsushita T, Hamaguchi Y et al (2012) Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy. Ann Rheum Dis 71(5):710\u2013713. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200697","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"6237_CR2","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1091\/mbc.E06-08-07473","volume":"18","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Yoshida N, Murakami N et al (2007) Dynamic regulation of p53 subnuclear localization and senescence by MORC3. Mol Biol Cell 18(5):1701\u20131709. https:\/\/doi.org\/10.1091\/mbc.E06-08-07473","journal-title":"Mol Biol Cell"},{"issue":"3","key":"6237_CR3","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s10067-020-05291-14","volume":"40","author":"L Li","year":"2021","unstructured":"Li L, Liu C, Cheng L, Yan S, Chen H, Li Y (2021) Assessment of diagnostic utility, clinical phenotypic associations, and prognostic significance of anti-NXP2 autoantibody in idiopathic inflammatory myopathies: a systematic review and meta-analysis. Clin Rheumatol 40(3):819\u2013832. https:\/\/doi.org\/10.1007\/s10067-020-05291-14","journal-title":"Clin Rheumatol"},{"issue":"4","key":"6237_CR4","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00296-013-2910-1","volume":"34","author":"R Neri","year":"2014","unstructured":"Neri R, Barsotti S, Iacopetti V et al (2014) Cancer-associated myositis: a 35-year retrospective study of a monocentric cohort. Rheumatol Int 34(4):565\u2013569. https:\/\/doi.org\/10.1007\/s00296-013-2910-1. (Epub 2013 Dec 10. Erratum in: Rheumatol Int. 2014 Apr;34(4):595. Simone, Barsotti [corrected to Barsotti, Simone]. PMID: 24322453)","journal-title":"Rheumatol Int"},{"issue":"2","key":"6237_CR5","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00296-022-05214-0","volume":"43","author":"S Izuka","year":"2023","unstructured":"Izuka S, Komai T, Shoda H, Fujio K (2023) Long-term risks of malignancy in myositis-specific antibody-positive idiopathic inflammatory myopathy. Rheumatol Int 43(2):335\u2013343. https:\/\/doi.org\/10.1007\/s00296-022-05214-0","journal-title":"Rheumatol Int"},{"issue":"4","key":"6237_CR6","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00296-012-2489-y","volume":"33","author":"V Limaye","year":"2013","unstructured":"Limaye V, Luke C, Tucker G et al (2013) The incidence and associations of malignancy in a large cohort of patients with biopsy-determined idiopathic inflammatory myositis. Rheumatol Int 33(4):965\u2013971. https:\/\/doi.org\/10.1007\/s00296-012-2489-y","journal-title":"Rheumatol Int"},{"issue":"12","key":"6237_CR7","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.autrev.2014.08.0115","volume":"13","author":"L Bodoki","year":"2014","unstructured":"Bodoki L, Nagy-Vincze M, Griger Z, Betteridge Z, Sz\u00f6ll\u0151si L, Dank\u00f3 K (2014) Four dermatomyositis-specific autoantibodies\u2014anti-TIF1\u03b3, anti-NXP2, anti-SAE and anti-MDA5\u2014in adult and juvenile idiopathic inflammatory myopathies. Autoimmun Rev 13(12):1211\u20131219. https:\/\/doi.org\/10.1016\/j.autrev.2014.08.0115","journal-title":"Autoimmun Rev"},{"issue":"11","key":"6237_CR8","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1002\/acr.23188","volume":"69","author":"J Albayda","year":"2017","unstructured":"Albayda J, Pinal-Fernandez I, Huang W et al (2017) Antinuclear matrix protein 2 autoantibodies and edema, muscle disease, and malignancy risk in dermatomyositis patients. Arthritis Care Res (Hoboken) 69(11):1771\u20131776. https:\/\/doi.org\/10.1002\/acr.23188","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"6237_CR9","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1002\/art.40491","volume":"70","author":"H Yang","year":"2018","unstructured":"Yang H, Lu X, Peng Q et al (2018) Differential clinical associations of anti-nuclear matrix protein 2 autoantibodies in patients with idiopathic inflammatory myopathies. Arthritis Rheumatol 70(8):1288\u20131297. https:\/\/doi.org\/10.1002\/art.40491","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"6237_CR10","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1093\/rheumatology\/keab518","volume":"61","author":"Y Ichimura","year":"2022","unstructured":"Ichimura Y, Konishi R, Shobo M et al (2022) Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rash. Rheumatology (Oxford) 61(3):1222\u20131227. https:\/\/doi.org\/10.1093\/rheumatology\/keab518","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"6237_CR11","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/ar3822","volume":"14","author":"A Ceribelli","year":"2012","unstructured":"Ceribelli A, Fredi M, Taraborelli M et al (2012) Anti-MJ\/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis\/dermatomyositis. Arthritis Res Ther 14(2):R97. https:\/\/doi.org\/10.1186\/ar3822. (PMID: 22546500)","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"6237_CR12","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/rheumatology\/kes033","volume":"51","author":"A Ishikawa","year":"2012","unstructured":"Ishikawa A, Muro Y, Sugiura K, Akiyama M (2012) Development of an ELISA for detection of autoantibodies to nuclear matrix protein 2. Rheumatology (Oxford) 51(7):1181\u20131187. https:\/\/doi.org\/10.1093\/rheumatology\/kes033. (PMID: 22427409)","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"6237_CR13","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1002\/acr.23210","volume":"69","author":"A Rogers","year":"2017","unstructured":"Rogers A, Chung L, Li S, Casciola-Rosen L, Fiorentino DF (2017) Cutaneous and systemic findings associated with nuclear matrix protein 2 antibodies in adult dermatomyositis patients. Arthritis Care Res (Hoboken) 69(12):1909\u20131914. https:\/\/doi.org\/10.1002\/acr.23210. (PMID:28129490;PMCID:PMC5529261)","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"10","key":"6237_CR14","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1007\/s10067-018-4216-x","volume":"37","author":"L Wang","year":"2018","unstructured":"Wang L, Huang L, Yang Y et al (2018) Calcinosis and malignancy are rare in Chinese adult patients with myositis and nuclear matrix protein 2 antibodies identified by an unlabeled immunoprecipitation assay. Clin Rheumatol 37(10):2731\u20132739. https:\/\/doi.org\/10.1007\/s10067-018-4216-x. (PMID: 30039266)","journal-title":"Clin Rheumatol"},{"key":"6237_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","volume":"101","author":"Z Betteridge","year":"2019","unstructured":"Betteridge Z, Tansley S, Shaddick G et al (2019) Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients. J Autoimmun 101:48\u201355. https:\/\/doi.org\/10.1016\/j.jaut.2019.04.001. (PMID:30992170;PMCID:PMC6580360)","journal-title":"J Autoimmun"},{"issue":"8","key":"6237_CR16","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1080\/17476348.2020.1767598","volume":"14","author":"J Bermudez","year":"2020","unstructured":"Bermudez J, Heim X, Bertin D et al (2020) Lung involvement associated with anti-NXP2 autoantibodies in inflammatory myopathies: a French monocenter series. Expert Rev Respir Med 14(8):845\u2013850. https:\/\/doi.org\/10.1080\/17476348.2020.1767598. (PMID: 32394768)","journal-title":"Expert Rev Respir Med"},{"issue":"8","key":"6237_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23307","volume":"34","author":"L Li","year":"2020","unstructured":"Li L, Liu C, Wang Q et al (2020) Analysis of myositis autoantibodies in Chinese patients with cancer-associated myositis. J Clin Lab Anal 34(8):e23307. https:\/\/doi.org\/10.1002\/jcla.23307. (PMID:32222002;PMCID:PMC7439325)","journal-title":"J Clin Lab Anal"},{"issue":"9","key":"6237_CR18","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1007\/s10067-021-05667-x","volume":"40","author":"TT Yan","year":"2021","unstructured":"Yan TT, Zhang X, Yang HH et al (2021) Association of anti-NXP2 antibody with clinical characteristics and outcomes in adult dermatomyositis: results from clinical applications based on a myositis-specific antibody. Clin Rheumatol 40(9):3695\u20133702. https:\/\/doi.org\/10.1007\/s10067-021-05667-x. (PMID: 33712891)","journal-title":"Clin Rheumatol"},{"issue":"2","key":"6237_CR19","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12016-021-08920-y","volume":"63","author":"M Fredi","year":"2022","unstructured":"Fredi M, Cavazzana I, Ceribelli A et al (2022) An Italian Multicenter Study on anti-NXP2 antibodies: clinical and serological associations. Clin Rev Allergy Immunol 63(2):240\u2013250. https:\/\/doi.org\/10.1007\/s12016-021-08920-y. (PMID:35092577;PMCID:PMC9464148)","journal-title":"Clin Rev Allergy Immunol"},{"key":"6237_CR20","doi-asserted-by":"publisher","first-page":"1200804","DOI":"10.3389\/fmed.2023.1200804","volume":"10","author":"ZL Tang","year":"2023","unstructured":"Tang ZL, Chi CC, Tang ZW, Li XW, Man XY (2023) Malignancy in dermatomyositis: a mono-centric retrospective study of 134 patients in China and a potential predictive model. Front Med (Lausanne) 10:1200804. https:\/\/doi.org\/10.3389\/fmed.2023.1200804. (PMID:37359002;PMCID:PMC10285222)","journal-title":"Front Med (Lausanne)"},{"issue":"12","key":"6237_CR21","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1007\/s10067-023-06751-0","volume":"42","author":"A Manwatkar","year":"2023","unstructured":"Manwatkar A, Padiyar S, Nair A et al (2023) Clinical profile of anti-NXP-2 antibody-positive inflammatory myositis and outcome in an Indian population. Clin Rheumatol 42(12):3289\u20133297. https:\/\/doi.org\/10.1007\/s10067-023-06751-0. (PMID: 37801141)","journal-title":"Clin Rheumatol"},{"issue":"11","key":"6237_CR22","doi-asserted-by":"publisher","first-page":"1340310","DOI":"10.3389\/fmed.2024.1340310","volume":"28","author":"J Marklund","year":"2024","unstructured":"Marklund J, Hanna B, Jin T, Pullerits R (2024) Myositis-associated antibodies predict the severity of lung involvement in adult patients with inflammatory myositis\u2014a cohort study of 70 adult patients with myositis in a single center. Front Med (Lausanne) 28(11):1340310. https:\/\/doi.org\/10.3389\/fmed.2024.1340310. (PMID:38606156;PMCID:PMC11007204)","journal-title":"Front Med (Lausanne)"},{"issue":"46","key":"6237_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000040605","volume":"103","author":"X Xie","year":"2024","unstructured":"Xie X, Dai X, Liu H, Xing Y (2024) A retrospective study for clinical characteristics of 293 patients with dermatomyositis. Medicine (Baltimore) 103(46):e40605. https:\/\/doi.org\/10.1097\/MD.0000000000040605. (PMID:39560562;PMCID:PMC11575960)","journal-title":"Medicine (Baltimore)"},{"issue":"16","key":"6237_CR24","doi-asserted-by":"publisher","first-page":"1674437","DOI":"10.3389\/fimmu.2025.1674437","volume":"6","author":"C Li","year":"2025","unstructured":"Li C, Zheng Y, Zhang Y et al (2025) Association of clinical features and myositis-specific antibodies in idiopathic inflammatory myopathy: a retrospective study from southern China. Front Immunol 6(16):1674437. https:\/\/doi.org\/10.3389\/fimmu.2025.1674437. (PMID:41280916;PMCID:PMC12631342)","journal-title":"Front Immunol"},{"issue":"2","key":"6237_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/clinpract15020031","volume":"15","author":"M Chihi","year":"2025","unstructured":"Chihi M, Barakat L, Benhayoun FZ et al (2025) Clinical features of dermatomyositis associated with myositis-specific antibodies in moroccan patients. Clin Pract 15(2):31. https:\/\/doi.org\/10.3390\/clinpract15020031. (PMID:39996701;PMCID:PMC11853990)","journal-title":"Clin Pract"},{"key":"6237_CR26","doi-asserted-by":"publisher","first-page":"4817275","DOI":"10.1155\/2017\/4817275","volume":"2017","author":"Z Butt","year":"2017","unstructured":"Butt Z, Patel L, Das MK, Mecoli CA, Ramji A (2017) NXP-2 positive dermatomyositis: a unique clinical presentation. Case Rep Rheumatol 2017:4817275. https:\/\/doi.org\/10.1155\/2017\/4817275. (PMID:28695037;PMCID:PMC5485271)","journal-title":"Case Rep Rheumatol"},{"issue":"28","key":"6237_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000011501","volume":"97","author":"L Su","year":"2018","unstructured":"Su L, Yang Y, Jia Y et al (2018) Anti-NXP2-antibody-positive immune-mediated necrotizing myopathy associated with acute myeloid leukemia: a case report. Medicine (Baltimore) 97(28):e11501. https:\/\/doi.org\/10.1097\/MD.0000000000011501. (PMID:29995816;PMCID:PMC6076171)","journal-title":"Medicine (Baltimore)"},{"key":"6237_CR28","doi-asserted-by":"publisher","DOI":"10.5070\/D326304798","author":"AM Cartron","year":"2020","unstructured":"Cartron AM, Osler M, Chung C, Trinidad JC (2020) Nuclear matrix protein 2 antibody-positive adult dermatomyositis: a case report and review of the literature. Dermatol Online J. https:\/\/doi.org\/10.5070\/D326304798","journal-title":"Dermatol Online J"},{"issue":"5","key":"6237_CR29","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1684\/ejd.2020.3858","volume":"30","author":"N Fushida","year":"2020","unstructured":"Fushida N, Kobayashi T, Oishi K et al (2020) A case of anti-NXP2 antibody-positive dermatomyositis with improvement of clinical symptoms and disappearance of autoantibody after resection of uterine cancer. Eur J Dermatol 30(5):612\u2013613. https:\/\/doi.org\/10.1684\/ejd.2020.3858. (PMID:32972905;PMCID:PMC8120498)","journal-title":"Eur J Dermatol"},{"issue":"4","key":"6237_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.22551\/2020.29.0704.10176","volume":"7","author":"N Khan","year":"2021","unstructured":"Khan N, Kazmi ZH, Alkhateb R (2021) A rare case of NXP-2 positive dermatomyositis. Arch Clin Cases 7(4):68\u201371. https:\/\/doi.org\/10.22551\/2020.29.0704.10176. (PMID:34754931;PMCID:PMC8565706)","journal-title":"Arch Clin Cases"},{"issue":"4","key":"6237_CR31","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1093\/rheumatology\/keab872","volume":"61","author":"Y Okada","year":"2022","unstructured":"Okada Y, Izumi R, Hosaka T et al (2022) Anti-NXP2 antibody-positive dermatomyositis developed after COVID-19 manifesting as type I interferonopathy. Rheumatology (Oxford) 61(4):e90\u2013e92. https:\/\/doi.org\/10.1093\/rheumatology\/keab872. (PMID:34850853;PMCID:PMC8690268)","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"6237_CR32","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1186\/s13256-022-03680-5","volume":"16","author":"M Loghman","year":"2022","unstructured":"Loghman M, Rahmanian E, Alikhani M et al (2022) Necrotizing autoimmune myositis following coronavirus disease 2019 infection: a case report. J Med Case Rep 16(1):488. https:\/\/doi.org\/10.1186\/s13256-022-03680-5. (PMID:36575546;PMCID:PMC9793820)","journal-title":"J Med Case Rep"},{"issue":"22","key":"6237_CR33","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.2169\/internalmedicine.9415-22","volume":"61","author":"T Suga","year":"2022","unstructured":"Suga T, Abe T, Oiwa H (2022) Anti-nuclear matrix protein 2 antibody-positive dermatomyositis associated with cervical cancer recurrence after 6 years of stable disease. Intern Med 61(22):3445\u20133448. https:\/\/doi.org\/10.2169\/internalmedicine.9415-22. (PMID:35400707;PMCID:PMC9751719)","journal-title":"Intern Med"},{"issue":"12","key":"6237_CR34","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.32502","volume":"14","author":"M Constante","year":"2022","unstructured":"Constante M, Barradas AR, Esteves AL, Pereira S, Silva L (2022) Dermatomyositis: a cancer red flag. Cureus 14(12):e32502. https:\/\/doi.org\/10.7759\/cureus.32502. (PMID:36660526;PMCID:PMC9845686)","journal-title":"Cureus"},{"issue":"4","key":"6237_CR35","doi-asserted-by":"publisher","first-page":"180","DOI":"10.37897\/RJR.2022.4.4","volume":"31","author":"E Juganaru","year":"2022","unstructured":"Juganaru E, Cobilinschi C, Constantinescu C et al (2022) Playing detective\u201d in a case of paraneoplastic polymyositis. Rom J Rheumatol 31(4):180\u2013183. https:\/\/doi.org\/10.37897\/RJR.2022.4.4","journal-title":"Rom J Rheumatol"},{"issue":"2","key":"6237_CR36","doi-asserted-by":"publisher","first-page":"rkad066","DOI":"10.1093\/rap\/rkad066","volume":"7","author":"Y Ueda","year":"2023","unstructured":"Ueda Y, Shimada K (2023) Nuclear matrix protein 2 antibody-positive dermatomyositis associated with hepatocellular carcinoma. Rheumatol Adv Pract. 7(2):rkad066. https:\/\/doi.org\/10.1093\/rap\/rkad066. (PMID: 37564124; PMCID: PMC10409891)","journal-title":"Rheumatol Adv Pract."},{"issue":"12","key":"6237_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2023-257288","volume":"16","author":"M Walsh","year":"2023","unstructured":"Walsh M, Bettendorf B, Zahn C (2023) Dermatomyositis presenting with diffuse calcinosis. BMJ Case Rep 16(12):e257288. https:\/\/doi.org\/10.1136\/bcr-2023-257288. (PMID:38103899;PMCID:PMC10728952)","journal-title":"BMJ Case Rep"},{"issue":"1","key":"6237_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1093\/mrcr\/rxae037","volume":"9","author":"R Naito","year":"2025","unstructured":"Naito R, Hiwa R, Inaba R et al (2025) A case of vesiculobullous dermatomyositis with anti-NXP-2 antibody without malignancy. Mod Rheumatol Case Rep 9(1):84\u201387. https:\/\/doi.org\/10.1093\/mrcr\/rxae037. (PMID: 39087257)","journal-title":"Mod Rheumatol Case Rep"},{"issue":"5","key":"6237_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.8884","volume":"12","author":"DM Shan","year":"2024","unstructured":"Shan DM, Gupta N, Ortega-Loayza AG, Shea S, Nandan A (2024) Anti-nuclear matrix protein 2 antibody-positive amyopathic dermatomyositis presenting in a patient with prostate cancer: a case report. Clin Case Rep 12(5):e8884. https:\/\/doi.org\/10.1002\/ccr3.8884. (PMID:38725932;PMCID:PMC11079545)","journal-title":"Clin Case Rep"},{"issue":"2","key":"6237_CR40","doi-asserted-by":"publisher","first-page":"454","DOI":"10.55563\/clinexprheumatol\/x0389r","volume":"42","author":"F Yao","year":"2024","unstructured":"Yao F, Deng L, Liao Z, Wen Z (2024) Primary pulmonary diffuse large B-cell lymphoma with anti-NXP2-positive dermatomyositis: a case report. Clin Exp Rheumatol 42(2):454\u2013455. https:\/\/doi.org\/10.55563\/clinexprheumatol\/x0389r. (PMID: 37650343)","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"6237_CR41","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.79178","volume":"17","author":"S Kondle","year":"2025","unstructured":"Kondle S, Cohen S (2025) A severe case of nuclear matrix protein-2-positive dermatomyositis with Negative Malignancy Workup. Cureus 17(2):e79178. https:\/\/doi.org\/10.7759\/cureus.79178. (PMID:40109820;PMCID:PMC11922495)","journal-title":"Cureus"},{"issue":"2","key":"6237_CR42","doi-asserted-by":"publisher","first-page":"rxaf047","DOI":"10.1093\/mrcr\/rxaf047","volume":"9","author":"S Patel","year":"2025","unstructured":"Patel S, Wei E, Huang A et al (2025) Anti-nuclear matrix protein 2 antibody-positive dermatomyositis associated with smouldering myeloma mimicking anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis: A case of digital gangrene, palmar papules, and scrotal rash. Mod Rheumatol Case Rep. 9(2):rxaf047. https:\/\/doi.org\/10.1093\/mrcr\/rxaf047. (PMID: 40679424)","journal-title":"Mod Rheumatol Case Rep."},{"issue":"1","key":"6237_CR43","doi-asserted-by":"publisher","first-page":"rxag016","DOI":"10.1093\/mrcr\/rxag016","volume":"10","author":"CA Mecoli","year":"2026","unstructured":"Mecoli CA, Viswanathan AN, Rosen A, Casciola-Rosen L (2026) Parallel course of calcinosis and cancer in a patient with anti-NXP2-positive dermatomyositis: a case report. Mod Rheumatol Case Rep. 10(1):rxag016. https:\/\/doi.org\/10.1093\/mrcr\/rxag016. (PMID: 41786612; PMCID: PMC13002130)","journal-title":"Mod Rheumatol Case Rep."},{"issue":"17","key":"6237_CR44","doi-asserted-by":"publisher","first-page":"1730968","DOI":"10.3389\/fimmu.2026.1730968","volume":"4","author":"Z Zhang","year":"2026","unstructured":"Zhang Z, Jiang D, Wei T, Long K (2026) Atypical dermatomyositis with positive anti-nuclear matrix protein 2 antibodies complicated by rhabdomyolysis syndrome: a case report and literature review. Front Immunol 4(17):1730968. https:\/\/doi.org\/10.3389\/fimmu.2026.1730968. (PMID:41716406;PMCID:PMC12913410)","journal-title":"Front Immunol"},{"key":"6237_CR45","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.70281","author":"A Sakai","year":"2026","unstructured":"Sakai A, Yamashita Y, Tanaka I et al (2026) Cutaneous lesions and lung squamous cell carcinoma both successfully controlled with chemoradiotherapy in a patient with cancer-associated clinically amyopathic dermatomyositis with anti-nuclear matrix protein 2 antibodies. J Dermatol. https:\/\/doi.org\/10.1111\/1346-8138.70281","journal-title":"J Dermatol"},{"issue":"2","key":"6237_CR46","doi-asserted-by":"publisher","first-page":"rkag022","DOI":"10.1093\/rap\/rkag022","volume":"10","author":"R Nakamura","year":"2026","unstructured":"Nakamura R, Sugimori Y, Makino J et al (2026) Anti-NXP2 antibody-positive dermatomyositis presenting as systemic capillary leak syndrome with cutaneous and gastrointestinal ulcers. Rheumatol Adv Pract. 10(2):rkag022. https:\/\/doi.org\/10.1093\/rap\/rkag022. (PMID: 41878558; PMCID: PMC13006202)","journal-title":"Rheumatol Adv Pract."},{"issue":"2","key":"6237_CR47","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s12016-022-08922-4","volume":"63","author":"M Marz\u0119cka","year":"2022","unstructured":"Marz\u0119cka M, Niemczyk A, Rudnicka L (2022) Autoantibody markers of increased risk of malignancy in patients with dermatomyositis. Clin Rev Allergy Immunol 63(2):289\u2013296. https:\/\/doi.org\/10.1007\/s12016-022-08922-4. (PMID:35147864;PMCID:PMC9464248)","journal-title":"Clin Rev Allergy Immunol"},{"issue":"12","key":"6237_CR48","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/s41584-023-01045-w","volume":"19","author":"AGS Oldroyd","year":"2023","unstructured":"Oldroyd AGS, Callen JP, Chinoy H et al (2023) International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative. Nat Rev Rheumatol 19(12):805\u2013817. https:\/\/doi.org\/10.1038\/s41584-023-01045-w. (PMID:37945774;PMCID:PMC10834225)","journal-title":"Nat Rev Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06237-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-026-06237-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-026-06237-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T03:37:22Z","timestamp":1786937842000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-026-06237-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":48,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["6237"],"URL":"https:\/\/doi.org\/10.1007\/s00296-026-06237-7","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]},"assertion":[{"value":"7 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests. All authors certify that they have no affiliations with or involvement in any organization or entity with any financial or non-financial interest in the subject matter or materials discussed in this manuscript.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Ethics Committee of All India Institute of Medical Sciences (AIIMS), Rishikesh, India.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and accompanying clinical information.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We confirm that no generative artificial intelligence (AI) tools were used for drafting or editing, analysis, interpretation, or preparation of this manuscript.","order":4,"name":"Ethics","label":"Artificial intelligence (AI) disclosure","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No external commercial editing service, medical writer, editorial agency, or professional manuscript-editing support was used in the preparation of this manuscript. The work was entirely written and revised by the authors.","order":5,"name":"Ethics","label":"Commercial editing support disclosure","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data supporting this case-based review are available from the corresponding author upon reasonable request.","order":6,"name":"Ethics","label":"Data availability statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"207"}}